LINDSEY ROBINS: Open Payments
NPI 1609491018 · ROCKY HILL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 24 payments from 11 companies in 2025. Trend: 2023 $279 · 2024 $492 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $122 |
| Galderma Laboratories, L.P. | 6 | $116 |
| E.R. Squibb & Sons, L.L.C. | 3 | $86 |
| LEO Pharma Inc. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $31 |
| Lilly USA, LLC | 1 | $30 |
| Incyte Corporation | 1 | $27 |
| GENZYME CORPORATION | 1 | $26 |
| PFIZER INC. | 1 | $21 |
Products named: TREMFYA, NEMLUVIO, Sotyktu, Winlevi, TALTZ, ANZUPGO, OPZELURA, DUPIXENT.
Industry payments across CT — which companies pay providers there.
